
South Africa: Medical Schemes Face Challenges in Diabetes Care Funding
In South Africa, diabetes was identified as the leading underlying natural cause of death for the third consecutive year in 2024, claiming 28,767 lives, highlighting a critical public health crisis and the urgent need for re-evaluation of current healthcare funding models for prevention and treatment.
This persistent and escalating mortality rate from diabetes carries significant legal and economic implications for various stakeholders, including medical schemes, employers, and the public health sector. The current funding mechanisms are proving inadequate to address the burden of the disease, leading to substantial long-term costs associated with complications like kidney and eye damage, heart attacks, and strokes. For legal practitioners, this situation raises concerns about potential litigation related to access to care, the scope of medical scheme benefits, and employer responsibilities regarding employee health and wellness, particularly given the estimated 70% of adults with diabetes who remain undiagnosed.
The legal context for diabetes care in South Africa is primarily shaped by the Medical Schemes Act 131 of 1998 and its associated regulations, which dictate the benefits medical schemes must provide, including prescribed minimum benefits (PMBs) for chronic conditions. The National Health Act 61 of 2003 provides the overarching framework for the public health system. Furthermore, the ongoing legislative process surrounding the National Health Insurance (NHI) Bill represents a potential paradigm shift in healthcare funding and provision, which could fundamentally alter how diabetes prevention, diagnosis, and treatment are financed and delivered across the country. The Occupational Health and Safety Act 85 of 1993 may also impose duties on employers regarding employee health.
Key parties involved in this complex issue include medical schemes, which face increasing pressure to balance immediate prevention costs against long-term complication expenses; employers, who bear the costs of lost productivity due to absenteeism and disability; healthcare providers; the Department of Health; the Council for Medical Schemes; and, most importantly, the millions of South African individuals affected by diabetes. The interaction between these parties is crucial for developing a more effective and sustainable approach to diabetes care.
Legal professionals advising medical schemes, employers, or healthcare providers must closely monitor legislative and regulatory developments, particularly concerning the NHI Bill and any amendments to the Medical Schemes Act, as these will directly impact funding models and service delivery. It is imperative for attorneys to review and advise on current benefit structures, risk management strategies, and potential liabilities related to the provision or lack of adequate diabetes care, ensuring compliance with PMB requirements and exploring proactive wellness programs to mitigate long-term costs and legal exposure.
How does this affect you?
Get an AI analysis of this article grounded in your jurisdictions, practice areas, and any policy documents you've uploaded to Wansom.
Finish Reading the Full Story and the Expert Analysis.
Get the latest legal & regulatory intelligence in South Africa
Wansom is AI and can make mistakes.
